Researchers track evolution of HIV antibody

Researchers at the Duke University School of Medicine tracked the evolution of a broadly neutralizing antibody that recognizes different HIV strains, which could lead to the design of a vaccine. Broadly neutralizing antibodies are typically produced after the patient's HIV population has diversified, researchers reported online in Nature.

View Full Article in:

Nature (free content) · New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Market Access Manager Electrophysiology HEOR (AEP) - 15000003NZ
Abbott
Menlo Park, CA
Sales Manager, Employer Programs
PartnerRe Health